South San Francisco, CA · Founded 2013 · Privately Held (backing)
Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning. CytoVale is based in South San Francisco, CA and was founded in 2013. Its last known valuation is $340 million. It has raised $228 million across 3 recorded rounds; the latest was a $16.4 million debt round in Dec 2020.
Last price · $/share
—
Implied valuation
$340.0M
Total raised
$228.2M
Last round
Debt
Dec 2020
Team — not yet on record
No current team members for CytoVale are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CytoVale with a free account
·The complete investor list: 35 names
·Watch CytoVale: the Monday email on marks, rounds and moves
